GlyCosmos Portal

GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source	Last Updated
PSICQUIC	March 30, 2022

Displaying entries **1151 - 1175** of **4050** in total

« First

‹ Prev

…

43

44

45

46

47

48

49

50

51

…

Next ›

Last »
Antibody	Patient	Onset (days)	Symptom	GlyTouCan ID	Arbitrary Fluorescence Units (AFU) ▲
IgM	Patient 1	6	moderate	G16579HJ	73
IgG	Patient 2	15	mild	G84224TW	73
IgM	Patient 2	15	mild	G21320TF	73
IgM	Patient 2	24	mild	G37036SF	73
IgG	Patient 3	-180	mild	G00068MO	73
IgG	Patient 3	-180	mild	G17140UR	73
IgM	Patient 3	-180	mild	G89993FE	73
IgG	Patient 3	11	mild	G72739GY	73
IgG	Patient 3	11	mild	G92022ML	73
IgG	Patient 3	4	mild	G21290RB	73
IgG	Patient 3	4	mild	G82779CI	73
IgM	Patient 3	11	mild	G86541PE	73
IgG	Patient 1	22	moderate	G94576MN	74
IgG	Patient 2	15	mild	G11460AB	74
IgG	Patient 2	15	mild	G72424VO	74
IgM	Patient 2	15	mild	G91237TK	74
IgM	Patient 2	15	mild	G92823JK	74
IgM	Patient 2	24	mild	G82942ZJ	74
IgM	Patient 3	-180	mild	G53168IY	74
IgM	Patient 3	-180	mild	G93351GM	74
IgG	Patient 3	11	mild	G21290RB	74
IgM	Patient 3	4	mild	G32473MI	74
IgG	Patient 4	12	mild	G21460SG	74
IgG	Patient 1	22	moderate	G86156UJ	75
IgM	Patient 1	10	moderate	G96557TJ	75